Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, IL
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of MABT5102A in Patients with Mild to Moderate Alzheimer’s Diseases
The purpose of this study is to investigate the safety and the effects, good and/or bad, of MABT5102A. The study is intended to find out what effects MABT5102A has on you and on your Alzheimer's Disease. The study will also test different routes of administration (ways of giving the drug - either into your vein or under your skin).
Please contact Alexian Brothers for more information on participation.
CW ID: 176863
Date Last Changed:
July 22, 2013
Alexian Brothers Hospital Network800 Biesterfield Road
Brock Building First FloorElk Grove Village, IL 60007Phone: 847-593-8553
Alexian Brothers Hospital Network
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.